Skip to main content
Download PDF

Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

The Journal of Headache and Pain volume 23, Article number: 64 (2022) Cite this article

The Original Article was published on 09 April 2022

Correction: J Headache Pain 23, 46 (2022)

https://doi.org/10.1186/s10194-022-01396-x

Following the publication of the original article [1], we were notified of a mistake in the abstract: the 100% response rate in HFEM at week 12 is 5.9% (as correctly reported in figure 3) and NOT 9.9% as reported in the abstract and page 5.

The original article has been corrected.

Reference

  1. Barbanti et al (2022) Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study). J Headache Pain 23:46. https://doi.org/10.1186/s10194-022-01396-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Headache and Pain Unit, IRCCS San Rafaele Pisana, Rome, Italy

    Piero Barbanti, Gabriella Egeo & Cinzia Aurilia

  2. San Rafaele University, Rome, Italy

    Piero Barbanti

  3. Neurology Unit, San Giuseppe Moscati Hospital, Avellino, Italy

    Florindo d’Onofrio

  4. Regional Referral Headache CenterNeurology Unit, University Hospital Tor Vergata, Rome, Italy

    Maria Albanese

  5. Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

    Maria Albanese

  6. Headache Unit, Department of Neurology, Scientifc Institute San Rafaele Hospital, Vita-Salute University, Via Olgettina, 48, Milan, Italy

    Ilaria Cetta

  7. Headache Center, ASST Santi Paolo Carlo, Milan, Italy

    Paola Di Fiore

  8. Headache Center, Neurlogy Unit, San Camillo-Forlanini Hospital, Rome, Italy

    Maurizio Zucco

  9. Neurology Unit, IRCCS San Rafaele Scientifc Institute, Vita-Salute San Raffaele University, Milan, Italy

    Massimo Filippi

  10. Center for Headache and Intracranial Pressure Disorders, Neurology Unit, A.O.U. Mater Domini, Catanzaro, Italy

    Francesco Bono

  11. Headache and Neurosonology Unit, Policlinico Universitario Campus Bio-Medico, Rome, Italy

    Claudia Altamura

  12. Clinical and Molecular Epidemiology, IRCCS San Rafaele, Roma, Italy

    Stefania Proietti & Stefano Bonassi

  13. Department of Human Sciences and Quality of Life Promotion, San Rafaele University, Rome, Italy

    Stefano Bonassi

  14. Headache and Neurosonology Unit, Campus BioMedico University Hospital, Rome, Italy

    Fabrizio Vernieri

Authors
  1. Piero Barbanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriella Egeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cinzia Aurilia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Florindo d’Onofrio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Albanese
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ilaria Cetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paola Di Fiore
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Maurizio Zucco
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Massimo Filippi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Francesco Bono
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Claudia Altamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Stefania Proietti
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Stefano Bonassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Fabrizio Vernieri
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the FRIEND-Study Group

Corresponding author

Correspondence to Piero Barbanti.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barbanti, P., Egeo, G., Aurilia, C. et al. Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study). J Headache Pain 23, 64 (2022). https://doi.org/10.1186/s10194-022-01434-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s10194-022-01434-8

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us